- Braun is one of the world's leading providers and manufacturers of healthcare solutions today.
The B. Braun mission is to protect and improve the health of people around the world. It is a mission driven by a powerful and lived ethos of collaboration and cooperation for the greater good – Sharing Expertise.
That means continuously developing effective healthcare solutions and services through constructive dialogue with our customers and partners.
“Through collaborative and constructive work alongside the NHS, we can improve patient outcomes for the long term.” – David Oates – Group Managing Director, B. Braun Group of companies in the UK.
With its constantly growing portfolio, B. Braun makes a substantial contribution towards protecting and improving people's health. In total, the B. Braun product range comprises 5,000 different products, 95 percent of which are manufactured by the company.
It comes from strong family foundations - B. Braun is the only family-owned organisation amongst the world’s 20 largest medical device companies.
These strong foundations and principles are not just reflected in the way we do business but the way we run the company with many of our 65,000-plus employees worldwide staying with the business throughout their careers. In the UK, B. Braun Medical Ltd holds Investors in People Gold Champion status.
We invest continually. In the last five years, B. Braun has invested more than 4 billion euros in its subsidiaries worldwide. Our investments make it possible to extend production capacities and guarantee that we remain a reliable partner for our customers in the future.
One of our key company values is innovation – healthcare is driven by innovation and advancement - and we invest over 350 million euros, or five percent of our sales, in research and development.
Driven by the vast economic challenge of ageing populations and, as we have seen in 2020, the fragility of our healthcare and economy to a global health crisis - there is growing recognition of the need for a shift from sick management to an holistic approach to health management.
Improving lifestyles and interventions to prevent illness is critical and B. Braun is driving the debate and delivery of some of those solutions.
It’s also in the interests of the NHS and industry to deliver high-quality healthcare in more efficient settings beyond hospitals. Clinical care in the community will be critical going forwards, as will the integration of care systems.
For example, B. Braun Avitum UK provides the NHS with a complete solution for Haemodialysis products and services. Today we operate 9 UK dialysis centres and continue to work in partnership with Trusts to address capacity demands and patient choice for Haemodialysis in the hospital, satellite unit and in the patients’ home.
Our TransCare high-tech homecare service within delivers both aseptically compounded products and nursing services to patients in their own home, helping to improve quality of life and supporting the move of consultant-led patient care to a community setting.
Advancements in clinical practice, remote technology and pharmaceuticals such as fast acting anaesthetics allow the process of surgery to be less invasive, quicker recovery and less confined to a hospital setting.
Using innovative technology, our BPMpathway empowers patients by providing them with a digital platform to complete a range of motion tests, to track their progress, log pain and remain in contact with the hospital, enabling healthcare providers and trusts to discharge patients having major knee surgery on the same day.
The foundation of our success as a family owned company is based on our core values of innovation, efficiency and sustainability. With a pioneering spirit and brave investments, we embrace these values and constantly innovate the health care market.
www.bbraun.co.uk
@BBraunUK
